Clinical Trial Update: A Safety and Efficacy Study for Infliximab (Remicade) in Patients With Ulcerative Colitis [Phase 3]

View source ↗

Summary

Phase 3 safety and efficacy evaluation of infliximab (Remicade) in patients with ulcerative colitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Infliximab (Remicade) (Infliximab)

Snippet

Sponsor: Centocor, Inc. | Conditions: Ulcerative Colitis | Phase 3 | Status: COMPLETED